NEXGEL, Inc. manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG Labs. The company offers over-the-counter remedy solutions such as blister and pain applications, as well as beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape for patients with impaired skin, and NEXDerm, an adhesive tape for securing central lines and intravenous tubes and devices. In addition, it engages in the converting and packaging business and serves customers under the Medagel, Kenkoderm, and Silly George brand names. Formerly known as AquaMed Technologies, Inc., it changed its name to NEXGEL, Inc. in November 2019. Incorporated in 2009, it is based in Langhorne, Pennsylvania.